Gwen Ambler Selected Research

Pneumonia (Pneumonitis)

8/2019	Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries.
9/2018	Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
1/2016	A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
1/2016	mPneumonia, an Innovation for Diagnosing and Treating Childhood Pneumonia in Low-Resource Settings: A Feasibility, Usability and Acceptability Study in Ghana.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gwen Ambler Research Topics

Disease

4	Pneumonia (Pneumonitis) 08/2019 - 01/2016
3	Infections 11/2021 - 01/2013
1	Cholera 11/2021
1	Diarrhea 11/2021
1	Neoplasms (Cancer) 01/2021
1	Glucosephosphate Dehydrogenase Deficiency 01/2021
1	Vivax Malaria 01/2021
1	Malaria 09/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Tetanus 01/2013
1	Whooping Cough (Pertussis) 01/2013
1	Diphtheria 01/2013

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2016
2	Amoxicillin (Wymox)FDA LinkGeneric 09/2018 - 01/2016
1	IOWH-032IBA 11/2021
1	Chloride Channels (Chloride Channel)IBA 11/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2021
1	rasburicase (Elitek)FDA Link 01/2021
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021
1	boldenone undecylenate (Equipoise)IBA 08/2019
1	TabletsIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2014
1	VaccinesIBA 01/2013
1	Complement System Proteins (Complement)IBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2013
1	Duration of Therapy 09/2018